# R6 — Answers to the red-team memos (line by line), 2026-11-11

Memos: `VRRM.md`, `ALIT.md`, `KLC.md`, `FMC.md` (one independent subagent pass per finalist). All four verdicts: WOUNDED. No KILL.
Every point below was accepted or answered from the cited filings; accepted points were written into `scripts/r5_math.py` and the math was re-run.

## VRRM — WOUNDED
1. Anchor rental-car contract already terminated (effective 2027-01-30) — **ACCEPTED.** Bear case rewritten; P(zero) +0.08.
2. Second anchor repriced, third in procurement — **ACCEPTED** (same adjustment).
3. Forward cash flow below TTM; capex $114M — **ACCEPTED.** The TTM figure stays in the row as a filed number; the survival adjustment carries the forward view.
4. Mix shift to NYCDOT at half the margin — **ACCEPTED** (no separate adjustment; same mechanism).
5. Debt mis-described: $350M notes due 2029-04-15 + $689M term loan due 2032 — **ACCEPTED, table corrected.** No covenant breach found.
6. Impairments, CEO and CFO turnover, interim CFO from Alvarez & Marsal — **ACCEPTED as risk**; the restructuring reading is the reviewer's inference, not a filing fact.
7. Class action — **ACCEPTED as risk**; no accrual stated.
8. 10x needs more than its pre-collapse price — **ACCEPTED**; the plausibility ceiling (18.7x) already sits above the old high and is the most aggressive input left.
Result: P(zero) 0.112 → 0.192; LIFT 2.5x → **2.2x**; EV +0.300 → +0.201.

## ALIT — WOUNDED
1. All $1,991M of debt is one term loan due 2028-08-31; refinancing talks failed and the company chose not to pursue one (8-K 2026-10-14, 0001628280-26-065893) — **ACCEPTED; cannot be answered from filings.** A 22-month maturity wall with no refinancing path is the single most likely route to total loss. P(zero) +0.25.
2. Unrestricted cash $212M, not $448M — **ACCEPTED, table corrected.**
3. EV/OCF ≈ 8.4x including net debt and the $448M tax receivable liability, not 1.1x — **ACCEPTED.**
4. Revenue −6.2%, client losses guided through FY2027 — **ACCEPTED.**
Result: P(zero) 0.098 → 0.348; LIFT **1.8x**; EV +0.031.

## KLC — WOUNDED
1. $1,584M operating leases on top of $926M debt — **PARTLY ANSWERED.** Leases are the normal cost of a centre-based operator and are already inside operating cash flow; but they are fixed claims if enrolment falls. P(zero) +0.05.
2. Occupancy −240 bp to 68.6%; Q2 operating income $2.4M vs $68.7M — **ACCEPTED.**
3. Q3 10-Q not yet on the mirror — **OPEN;** re-read before the lock.
Result: P(zero) 0.106 → 0.156; LIFT **2.3x**; EV +0.232.

## FMC — WOUNDED, close to KILL
1. Q3 revenue −80% on price cuts and a new rebate model, not the crop cycle — **ACCEPTED; my wave line was wrong.**
2. "Cash-positive $426M" was continuing operations lapping a bad prior year; YTD operating cash flow is −$231M — **ACCEPTED.** Re-modelled as a cash burner (≈ −$300M/yr).
3. Leverage covenant suspended Q1–Q3 2026 and re-tested from Q4 2026 at 6.75x; equity −$19M against $4.18B debt — **ACCEPTED; cannot be answered** (the Q4 EBITDA is not knowable today). P(zero) +0.15.
4. Tessenderlo bought ~20% at $13.30 — noted; a strategic floor is possible but not promised by any filing.
Result: P(zero) 0.101 → 0.373; dilution 3.0x by year 5 on the flat path; EV **−0.508**.

## Outcome
After the red team, **none of the four clears the NO-TRADE bar** (LIFT ≥ 2.5x and EV > 0):
VRRM 2.2x / +0.201 · KLC 2.3x / +0.232 · ALIT 1.8x / +0.031 · FMC 2.4x / −0.508.
They move to the paper shadow book. The only route to a non-empty buy set is a new survivor from the VA verification batches that passes the math AND its own red-team pass before Sun Nov 15.
